Vasopressin, Epinephrine, and Steroids for Cardiac Arrest
Status:
Completed
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
The simultaneous activation of adrenergic and vasopressin receptors, in conjunction with a
potential steroid-mediated enhancement of the vascular reactivity to epinephrine may have
beneficial effects in patients with cardiac arrest. This hypothesis is supported by the
single-center results of NCT 00411879. The investigators intend to either refute or provide
definitive evidence supporting this hypothesis (and its generalizability) by conducting the
present multicenter, randomized, controlled clinical trial of in hospital cardiac arrest.